Abstract
Treatment of acute hepatitis C virus (HCV) infection is associated with a 98% sustained virologic response (SVR) rate in monoinfected patients ( N Engl J Med 2001; 345:1452), but how effective is it in HIV-coinfected patients? To address this question, investigators in France conducted a pilot study among 25 men with HIV and acute HCV infection. During a 12-week observation period, only one man spontaneously cleared his HCV infection; five others withdrew from the study. The remaining 19 men were given a 24-week course of pegylated interferon …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
